Cargando…

AAV2-antiVEGFscFv gene therapy for retinal neovascularization

Retinal neovascularization (NV) may lead to irreversible vision impairment, the main treatment for which is the inhibition of vascular endothelial growth factor (VEGF). Existing drugs show limited clinical benefits because of their high prices and short half-lives, which increase the financial burde...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Ni, Xu, Xin, Liu, Ying, Luo, Guangzuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679950/ https://www.ncbi.nlm.nih.gov/pubmed/38027065 http://dx.doi.org/10.1016/j.omtm.2023.101145

Ejemplares similares

Suppression of Choroidal Neovascularization by AAV-Based Dual-Acting Antiangiogenic Gene Therapy
por: Askou, Anne Louise, et al.
Publicado: (2019)

Evaluation of AAV-DJ vector for retinal gene therapy
por: Katada, Yusaku, et al.
Publicado: (2019)

Immunogenicity of Novel AAV Capsids for Retinal Gene Therapy
por: Gehrke, Miranda, et al.
Publicado: (2022)

AAV2/8 Anti-angiogenic Gene Therapy Using Single-Chain Antibodies Inhibits Murine Choroidal Neovascularization
por: Hughes, Chris P., et al.
Publicado: (2018)

Efficacious, safe, and stable inhibition of corneal neovascularization by AAV-vectored anti-VEGF therapeutics
por: Su, Wenqi, et al.
Publicado: (2021)

Anti-AAV Antibodies in AAV Gene Therapy: Current Challenges and Possible Solutions
por: Weber, Thomas
Publicado: (2021)

Retinal pigment epithelial cell expression of active Rap 1a by scAAV2 inhibits choroidal neovascularization
por: Wang, Haibo, et al.
Publicado: (2016)

Adeno-Associated Virus (AAV) - Based Gene Therapies for Retinal Diseases: Where are We?
por: Ail, Divya, et al.
Publicado: (2023)

Aggregation-Inhibiting scFv-Based Therapies Protect Mice against AAV1/2-Induced A53T-α-Synuclein Overexpression
por: Schlichtmann, Benjamin W., et al.
Publicado: (2023)

The Signalling Role of the αvβ5-Integrin Can Impact the Efficacy of AAV in Retinal Gene Therapy
por: Cronin, Therese, et al.
Publicado: (2012)

Ad- and AAV8-mediated ABCA1 gene therapy in a murine model with retinal ischemia/reperfusion injuries
por: Luo, Jing, et al.
Publicado: (2021)

An AAV-Based NF-κB-Targeting Gene Therapy (rAAV-DMP-miR533) to Inflammatory Diseases
por: Luo, Tao, et al.
Publicado: (2022)

AAV-mediated gene augmentation therapy of CRB1 patient-derived retinal organoids restores the histological and transcriptional retinal phenotype
por: Boon, Nanda, et al.
Publicado: (2023)

AAV-mediated gene augmentation therapy of CRB1 patient-derived retinal organoids restores the histological and transcriptional retinal phenotype
por: Boon, Nanda, et al.
Publicado: (2023)

Immunogenicity and toxicity of AAV gene therapy
por: Ertl, Hildegund C. J.
Publicado: (2022)

AAV gene therapy vectors in the TMJ
por: Brouxhon, Sabine M., et al.
Publicado: (2022)

Quantitative assessment of retinal fluid in neovascular age-related macular degeneration under anti-VEGF therapy
por: Reiter, Gregor S., et al.
Publicado: (2022)

Adeno‐associated virus (AAV)-based gene therapy for glioblastoma
por: Xu, Xin, et al.
Publicado: (2021)

Delivery of CR2-fH Using AAV Vector Therapy as Treatment Strategy in the Mouse Model of Choroidal Neovascularization
por: Schnabolk, Gloriane, et al.
Publicado: (2017)

Anti-Scg3 Gene Therapy to Treat Choroidal Neovascularization in Mice
por: Huang, Chengchi, et al.
Publicado: (2023)

Retinal neovascularization and its regression on doxycycline in epidemic retinitis
por: Reddy, Subhakar, et al.
Publicado: (2020)

Co-culture of Retinal and Endothelial Cells Results in the Modulation of Genes Critical to Retinal Neovascularization
por: Kumar, Ravindra, et al.
Publicado: (2011)

Peripapillary Intravitreal Injection Improves AAV-Mediated Retinal Transduction
por: Madrakhimov, Sanjar Batirovich, et al.
Publicado: (2020)

Slit-miR-218-Robo axis regulates retinal neovascularization
por: Kong, Yichun, et al.
Publicado: (2016)

Editorial: “AAV Gene Therapy: Immunology and Immunotherapeutics”
por: Martinez-Navio, José M., et al.
Publicado: (2021)

Editorial: Immunogenicity and toxicity of AAV gene therapy
por: Bradbury, Allison, et al.
Publicado: (2023)

Reduction of retinal ganglion cell death in mouse models of familial dysautonomia using AAV-mediated gene therapy and splicing modulators
por: Schultz, Anastasia, et al.
Publicado: (2023)

The Architecture of Macular Neovascularizations Predicts Treatment Responses to Anti-VEGF Therapy in Neovascular AMD
por: Faatz, Henrik, et al.
Publicado: (2022)

Targeting Neuroinflammation in Neovascular Retinal Diseases
por: Wang, Tianxi, et al.
Publicado: (2020)

Factors Impacting Efficacy of AAV-Mediated CRISPR-Based Genome Editing for Treatment of Choroidal Neovascularization
por: Chung, Sook Hyun, et al.
Publicado: (2020)

Delivery of nVEGFi using AAV8 for the treatment of neovascular age-related macular degeneration
por: She, Kaiqin, et al.
Publicado: (2022)

Photo‐mediated ultrasound therapy for the treatment of retinal neovascularization in rabbit eyes
por: Qin, Yu, et al.
Publicado: (2022)

Evaluating Efficiencies of Dual AAV Approaches for Retinal Targeting
por: Carvalho, Livia S., et al.
Publicado: (2017)

Construction and Periplasmic Expression of the Anti-EGFRvIII ScFv Antibody Gene in Escherichia coli
por: Dewi, Kartika Sari, et al.
Publicado: (2016)

Neovascular Progression and Retinal Dysfunction in the Laser-Induced Choroidal Neovascularization Mouse Model
por: Salas, Anna, et al.
Publicado: (2023)

Correction: Co-culture of Retinal and Endothelial Cells Results in the Modulation of Genes Critical to Retinal Neovascularization
por: Kumar, Ravindra, et al.
Publicado: (2012)

Development of an inducible anti-VEGF rAAV gene therapy strategy for the treatment of wet AMD
por: Reid, Christopher A., et al.
Publicado: (2018)

Significant changes in endogenous retinal gene expression assessed 1 year after a single intraocular injection of AAV-CNTF or AAV-BDNF
por: LeVaillant, Chrisna J, et al.
Publicado: (2016)

Inhibition of pathological retinal neovascularization by semaphorin 3A
por: Yu, Wenzhen, et al.
Publicado: (2013)

FV Vectors as Alternative Gene Vehicles for Gene Transfer in HSCs
por: Simantirakis, Emmanouil, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_me4skb9fmbcavj35eb8fu82djc